Ensol Biosciences Inc. (XKON:140610)
15,800
-280 (-1.74%)
At close: Jan 28, 2026
Ensol Biosciences Market Cap
Ensol Biosciences has a market cap or net worth of 187.72 billion as of January 29, 2026. Its market cap has decreased by -4.14% in one year.
Market Cap
187.72B
Enterprise Value
n/a
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
15,800.00
Market Cap Chart
Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 187.72B, an increase of 76.75%. That is a compound annual growth rate of 8.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 187.72B | 6.91% |
| Dec 30, 2025 | 175.59B | -10.18% |
| Dec 30, 2024 | 195.49B | 264.72% |
| Dec 28, 2023 | 53.60B | -23.21% |
| Dec 29, 2022 | 69.80B | -47.06% |
| Dec 30, 2021 | 131.85B | 5.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ISU Abxis | 244.95B |
| Vaxcell-Bio Therapeutics | 240.02B |
| Prestige Biologics | 233.26B |
| Kangstem Biotech | 202.22B |
| Bio Solution | 192.90B |
| curacle co.,ltd. | 186.77B |
| CORESTEMCHEMON | 171.45B |
| ViGenCell | 169.94B |